Non-invasive assessment of liver fibrosis by transient elastography in post transfusional iron overload

European Journal of Haematology

Volumn 80, Issue 4, 2008, Pages 337-340

  Mirault, Tristan ^b   Lucidarme, Damien ^b   Turlin, Bruno ^c   Vandevenne, Philippe ^b   Gosset, Pierre ^b   Ernst, Olivier ^d   Rose, Christian ^a,b  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b UNIVERSITÉ CATHOLIQUE DE LILLE   (France)

^c PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

FibroScan; Hepatic fibrosis; Iron overload; Liver iron content; Transient elastography

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; ELASTOGRAPHY; FEMALE; HIGH RISK PATIENT; HUMAN; IRON OVERLOAD; LIVER BIOPSY; LIVER FIBROSIS; LIVER HISTOLOGY; LONG TERM CARE; MALE; NON INVASIVE PROCEDURE; PATIENT IDENTIFICATION; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD;

EID: 40449106074     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2007.01011.x     Document Type: Article

References (21)

1. 1 Angelucci E, Muretto P, Lucarelli G, Ripalti M, Baronciani D, Erer B, Galimberti M, Giardini C, Gaziev D, Polchi P. Phlebotomy to reduce iron overload in patients cured of thalassemia by bone marrow transplantation. Italian Cooperative Group for Phlebotomy Treatment of Transplanted Thalassemia Patients. Blood 1997 ; 90: 994–8.
2. 2 Olivieri NF. The beta‐thalassemias. N Engl J Med 1999 ; 341: 99–109.
3. 3 Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 2000 ; 32: 477–81.
4. 4 Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, Darriet M, Couzigou P, De Ledinghen V. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005 ; 128: 343–50.
5. 5 Blanc JF, Bioulac‐Sage P, Balabaud C, Desmouliere A. Investigation of liver fibrosis in clinical practice. Hepatol Res 2005 ; 32: 1–8.
6. 6 Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003 ; 29: 1705–13.
7. 7 Saito H, Tada S, Nakamoto N, Kitamura K, Horikawa H, Kurita S, Saito Y, Iwai H, Ishii H. Efficacy of non‐invasive elastometry on staging of hepatic fibrosis. Hepatol Res 2004 ; 29: 97–103.
8. 8 Ziol M, Handra‐Luca A, Kettaneh A, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005 ; 41: 48–54.
9. 9 De Ledinghen V, Douvin C, Kettaneh A, Ziol M, Roulot D, Marcellin P, Dhumeaux D, Beaugrand M. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus‐coinfected patients. J Acquir Immune Defic Syndr 2006 ; 41: 175–9.
10. 10 Foucher J, Chanteloup E, Vergniol J, Castera L, Le Bail B, Adhoute X, Bertet J, Couzigou P, De Ledinghen V. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006 ; 55: 403–8.
11. 11 Foucher J, Castera L, Bernard PH, Adhoute X, Laharie D, Bertet J, Couzigou P, De Ledinghen V. Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol 2006 ; 18: 411–2.
12. 12 Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996 ; 24: 289–93.
13. 13 Barry M, Sherlock S. Measurement of liver‐iron concentration in needle‐biopsy specimens. Lancet 1971 ; 1: 100–3.
14. 14 Gandon Y, Olivie D, Guyader D, Aube C, Oberti F, Sebille V, Deugnier Y. Non‐invasive assessment of hepatic iron stores by MRI. Lancet 2004 ; 363: 357–62.
15. 15 Ernst O, Sergent G, Bonvarlet P, Canva‐Delcambre V, Paris JC, L’Hermine C. Hepatic iron overload: diagnosis and quantification with MR imaging. AJR Am J Roentgenol 1997 ; 168: 1205–8.
16. 16 Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2‐star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001 ; 22: 2171–9.
17. 17 Bassett ML, Halliday JW, Powell LW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology 1986 ; 6: 24–9.
18. 18 Jensen PD, Jensen FT, Christensen T, Nielsen JL, Ellegaard J. Relationship between hepatocellular injury and transfusional iron overload prior to and during iron chelation with desferrioxamine: a study in adult patients with acquired anemias. Blood 2003 ; 101: 91–6.
19. 19 Wood JC, Enriquez C, Ghugre N, Tyzka JM, Carson S, Nelson MD, Coates TD. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion‐dependent thalassemia and sickle cell disease patients. Blood 2005 ; 106: 1460–5.
20. 20 Rose C, Vandevenne P, Bourgeois E, Cambier N, Ernst O. Liver iron content assessment by routine and simple magnetic resonance imaging procedure in highly transfused patients. Eur J Haematol 2006 ; 77: 145–9.
21. 21 Jensen PD. Evaluation of iron overload. Br J Haematol 2004 ; 124: 697–711.